Y. Peng

Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells

U. Lendahl, G. Sonenshein, B. Osborne, 2008, Oncogene.

Significant response to apatinib monotherapy in heavily pretreated advanced HER2-positive breast cancer: a case report and literature review

Z. Lingyun, X. Qu, W. Jian, 2020, Cancer biology & therapy.

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

A. Palumbo, H. Dombret, B. Quesnel, 2014 .

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer

D. Rahardja, V. Sarode, E. King, 2012, British Journal of Cancer.

Efficacy and safety of first‐line treatments for patients with advanced anaplastic lymphoma kinase mutated, non–small cell cancer: A systematic review and network meta‐analysis

Yingying Ma, Qiang Zhao, D. Ma, 2023, Cancer.